首页> 美国卫生研究院文献>Cancers >Tumor Suppressor Protein p53 and Inhibitor of Apoptosis Proteins in Colorectal Cancer—A Promising Signaling Network for Therapeutic Interventions
【2h】

Tumor Suppressor Protein p53 and Inhibitor of Apoptosis Proteins in Colorectal Cancer—A Promising Signaling Network for Therapeutic Interventions

机译:肿瘤抑制蛋白P53和结肠直肠癌中凋亡蛋白的抑制剂 - 用于治疗干预的有希望的信号网络

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Tumor suppressor 53 (p53) is a multifunctional protein that regulates cell cycle, DNA repair, apoptosis and metabolic pathways. In colorectal cancer (CRC), mutations of the gene occur in 60% of patients and are associated with a more aggressive tumor phenotype and resistance to anti-cancer therapy. In addition, inhibitor of apoptosis (IAP) proteins are distinguished biomarkers overexpressed in CRC that impact on a diverse set of signaling pathways associated with the regulation of apoptosis/autophagy, cell migration, cell cycle and DNA damage response. As these mechanisms are further firmly controlled by p53, a transcriptional and post-translational regulation of IAPs by p53 is expected to occur in cancer cells. Here, we aim to review the molecular regulatory mechanisms between IAPs and p53 and discuss the therapeutic potential of targeting their interrelationship by multimodal treatment options.
机译:肿瘤抑制剂53(p53)是一种多功能蛋白,调节细胞周期,DNA修复,细胞凋亡和代谢途径。在结直肠癌(CRC)中,基因的突变发生在60%的患者中,与更积极的肿瘤表型和抗癌治疗抗性相关。此外,细胞凋亡(IAP)蛋白的抑制剂是在CRC中过表达过表达的显着的生物标志物,其影响与细胞凋亡/自噬,细胞迁移,细胞周期和DNA损伤反应的调节相关的各种信号传导途径。由于这些机制进一步牢固地由P53控制,因此预期P53对IAP的转录和翻译后调节在癌细胞中发生。在这里,我们的目的是在IAP和P53之间审查分子调节机制,并讨论多式化治疗方案靶向其相互关系的治疗潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号